16/10/2013 - 12:23

NZ biotech chooses Australia for IPO

16/10/2013 - 12:23

Bookmark

Save articles for future reference.

Perth based stockbroking firm Patersons Securities is punting on investors’ emerging appetite for biotech stocks, agreeing to underwrite New Zealand biopharmaceutical company Innate Immunotherapeutics’s $16.5 million initial public offering.

This article is only available to our paid subscribers.

To read this article and get full access to every insight Business News offers, subscribe today.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options